As long as your treatment is legitimate and your levels are acceptable, you should be able to donate without issue
View in: Pubmed Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice
Peris K, Fargnoli M C, Garbe C et al
Consistent with the WHI clinical trial, observational studies have also reported an increased risk of breast cancer with estrogen plus progestin therapy, and a smaller increase in the risk for breast cancer with estrogen-alone therapy, after several years of use
Get Your Custom Plan Receive your personalized weight loss plan, including GLP-1s like semaglutide (for those who qualify), supplements, and lifestyle strategies recommended by your Lifeforce clinician
FDA Disclaimer: These statements have not been evaluated by the FDA.